D-0498-2025 Class II Ongoing
FDA drug recall D-0498-2025 was initiated by Tailstorm Health INC on Jun 2, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process. The recall status is ongoing. Affected quantity: 29,700 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 9, 2025
- Initiation Date
- Jun 2, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 29,700 vials
Product description
LIDOcaine HCl Injection, USP, 10mg/mL, 1% (100 mg/10mL), 10 mL Sterile Single Dose Vial, Rx Only, For Infiltration & Nerve Block, Including Caudal & Epidural Use, Preservative-Free, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0000-0.
Reason for recall
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Distribution pattern
Nationwide in the US
Code information
Lot #s: 2502004, Exp. 2/18/27; 2503003, Exp. 3/19/27
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0498-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026